People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Pharmaceuticals, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eyenovia, Inc. | — | Pharmaceuticals | Series C | $66.0M | $312.3M | 2016 |
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
| Betaliq Inc | — | Biotechnology | Series A | $6.4M | $1.4M | 2019 |
| Forwardvue Pharma, Inc. | — | Pharmaceuticals | Seed | $5.0M | $11.3M | 2020 |
| Kurobe Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2013 |
| SubioMed, Inc. | — | Other Health Care | Pre-Seed | $283K | $8.7M | 2019 |
BARRY BUTLER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside BARRY BUTLER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Curt LaBelle | 2 | 7 |
| Peter Barrett | 1 | 18 |
| Christopher Jones | 1 | 9 |
| Ernest Mario | 1 | 9 |
| Anthony Sun | 1 | 8 |
| John Deedrick | 1 | 7 |
| Charles Cohen | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| FRED ESHELMAN | 1 | 5 |
| Anthony Maida | 1 | 5 |
| Tsontcho Ianchulev | 1 | 5 |
| Todd Creech | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| Amir Shojaei | 1 | 3 |
| John Gandolfo | 1 | 2 |
| Charles Mather | 1 | 2 |
| Rachel Jacobson | 1 | 2 |
| Kenneth Lee | 1 | 2 |
| Fredric Eshelman | 1 | 2 |
| Thomas Riedhammer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.